BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 33475909)

  • 1. Insulin sensitivity in critically ill patients: are women more insulin resistant?
    Uyttendaele V; Chase JG; Knopp JL; Gottlieb R; Shaw GM; Desaive T
    Ann Intensive Care; 2021 Jan; 11(1):12. PubMed ID: 33475909
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Untangling glycaemia and mortality in critical care.
    Uyttendaele V; Dickson JL; Shaw GM; Desaive T; Chase JG
    Crit Care; 2017 Jun; 21(1):152. PubMed ID: 28645302
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 3D kernel-density stochastic model for more personalized glycaemic control: development and in-silico validation.
    Uyttendaele V; Knopp JL; Davidson S; Desaive T; Benyo B; Shaw GM; Chase JG
    Biomed Eng Online; 2019 Oct; 18(1):102. PubMed ID: 31640720
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reducing the impact of insulin sensitivity variability on glycaemic outcomes using separate stochastic models within the STAR glycaemic protocol.
    Thomas F; Pretty CG; Fisk L; Shaw GM; Chase JG; Desaive T
    Biomed Eng Online; 2014 Apr; 13():43. PubMed ID: 24739335
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Generalisability of a Virtual Trials Method for Glycaemic Control in Intensive Care.
    Dickson JL; Stewart KW; Pretty CG; Flechet M; Desaive T; Penning S; Lambermont BC; Benyo B; Shaw GM; Chase JG
    IEEE Trans Biomed Eng; 2018 Jul; 65(7):1543-1553. PubMed ID: 28358672
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Day-to-day fasting glycaemic variability in DEVOTE: associations with severe hypoglycaemia and cardiovascular outcomes (DEVOTE 2).
    Zinman B; Marso SP; Poulter NR; Emerson SS; Pieber TR; Pratley RE; Lange M; Brown-Frandsen K; Moses A; Ocampo Francisco AM; Barner Lekdorf J; Kvist K; Buse JB;
    Diabetologia; 2018 Jan; 61(1):48-57. PubMed ID: 28913575
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nutrition delivery of a model-based ICU glycaemic control system.
    Stewart KW; Chase JG; Pretty CG; Shaw GM
    Ann Intensive Care; 2018 Jan; 8(1):4. PubMed ID: 29330610
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evolution of insulin sensitivity and its variability in out-of-hospital cardiac arrest (OHCA) patients treated with hypothermia.
    Sah Pri A; Chase JG; Pretty CG; Shaw GM; Preiser JC; Vincent JL; Oddo M; Taccone FS; Penning S; Desaive T
    Crit Care; 2014 Oct; 18(5):586. PubMed ID: 25349023
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Repaglinide : a pharmacoeconomic review of its use in type 2 diabetes mellitus.
    Plosker GL; Figgitt DP
    Pharmacoeconomics; 2004; 22(6):389-411. PubMed ID: 15099124
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prospective evaluation of a dynamic insulin infusion algorithm for non critically-ill diabetic patients: A before-after study.
    Montanier N; Bernard L; Lambert C; Pereira B; Desbiez F; Terral D; Abergel A; Bohatier J; Rosset E; Schmidt J; Sautou V; Hadjadj S; Batisse-Lignier M; Tauveron I; Maqdasy S; Roche B
    PLoS One; 2019; 14(1):e0211425. PubMed ID: 30689675
    [TBL] [Abstract][Full Text] [Related]  

  • 11. First pilot trial of the STAR-Liege protocol for tight glycemic control in critically ill patients.
    Penning S; Le Compte AJ; Moorhead KT; Desaive T; Massion P; Preiser JC; Shaw GM; Chase JG
    Comput Methods Programs Biomed; 2012 Nov; 108(2):844-59. PubMed ID: 21885150
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of a low carbohydrate formula on glycaemia in critically ill enterally-fed adult patients with hyperglycaemia: A blinded randomised feasibility trial.
    Doola R; Deane AM; Tolcher DM; Presneill JJ; Barrett HL; Forbes JM; Todd AS; Okano S; Sturgess DJ
    Clin Nutr ESPEN; 2019 Jun; 31():80-87. PubMed ID: 31060838
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of variation in patient response on model-based control of glycaemia in critically ill patients.
    Le Compte AJ; Pretty CG; Lin J; Shaw GM; Lynn A; Chase JG
    Comput Methods Programs Biomed; 2013 Feb; 109(2):211-9. PubMed ID: 21940063
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tight glycaemic control: a prospective observational study of a computerised decision-supported intensive insulin therapy protocol.
    Shulman R; Finney SJ; O'Sullivan C; Glynne PA; Greene R
    Crit Care; 2007; 11(4):R75. PubMed ID: 17623086
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Glycaemic variability and its association with enteral and parenteral nutrition in critically ill ventilated patients.
    Doola R; Greer RM; Hurford R; Flatley C; Forbes JM; Todd AS; Joyce CJ; Sturgess DJ
    Clin Nutr; 2019 Aug; 38(4):1707-1712. PubMed ID: 30170779
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk and reward: extending stochastic glycaemic control intervals to reduce workload.
    Uyttendaele V; Knopp JL; Shaw GM; Desaive T; Chase JG
    Biomed Eng Online; 2020 Apr; 19(1):26. PubMed ID: 32349750
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased insulin resistance in intensive care: longitudinal retrospective analysis of glycaemic control patients in a New Zealand ICU.
    Knopp JL; Chase JG; Shaw GM
    Ther Adv Endocrinol Metab; 2021; 12():20420188211012144. PubMed ID: 34123348
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of glucocorticoids on insulin resistance in the critically ill.
    Pretty C; Chase JG; Lin J; Shaw GM; Le Compte A; Razak N; Parente JD
    Comput Methods Programs Biomed; 2011 May; 102(2):172-80. PubMed ID: 20801543
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nutrition delivery, workload and performance in a model-based ICU glycaemic control system.
    Stewart KW; Chase JG; Pretty CG; Shaw GM
    Comput Methods Programs Biomed; 2018 Nov; 166():9-18. PubMed ID: 30415721
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.